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Summary
NovP is an S-adenosyl-L-methionine-dependent O-methyltransferase that catalyses the penultimate
step in the biosynthesis of the aminocoumarin antibiotic novobiocin. Specifically, it methylates at
the 4-OH of the noviose moiety, and the resultant methoxy group is important for the potency of the
mature antibiotic: previous crystallographic studies have shown that this group interacts directly with
the target enzyme DNA gyrase, which is a validated drug target. We have determined the high
resolution crystal structure of NovP from Streptomyces spheroides as a binary complex with its
desmethylated co-substrate, S-adenosyl-L-homocysteine. The structure displays a typical class I
methyltransferase fold, in addition to motifs that are consistent with a divalent metal-dependent
mechanism. This is the first representative structure of a methyltransferase from the TylF
superfamily, which includes a number of enzymes implicated in the biosynthesis of antibiotics and
other therapeutics. The NovP structure reveals a number of distinctive structural features that, based
on sequence conservation, are likely to be characteristic of the superfamily. These include a helical
'lid' region that gates access to the co-substrate binding pocket, and an active centre that contains a
3-Asp putative metal-binding site. A further conserved Asp likely acts as the general base that initiates
the reaction by deprotonating the 4-OH group of the noviose unit. Using in silico docking we have
generated models of the enzyme-substrate complex that are consistent with the proposed mechanism.
Furthermore, these models suggest that NovP is unlikely to tolerate significant modifications at the
noviose moiety, but could show increasing substrate promiscuity as a function of the distance of the
modification from the methylation site. These observations could inform future attempts to utilise
NovP for methylating a range of glycosylated compounds.
© 2009 Elsevier Ltd. All rights reserved.
*david.lawson@bbsrc.ac.uk.
Present addresses: I. Gómez García, Structural Biology Unit, CIC-bioGUNE, Bizkaia Technology Park, 48160 Derio, Bizkai, Spain; C.
L. Freel Meyers, Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
21205, USA
†IGG and CEMS contributed equally to this work
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
PDB accession code
Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 2WK1.
NIH Public Access
Author Manuscript
J Mol Biol. Author manuscript; available in PMC 2011 January 15.
Published in final edited form as:














O-methyltransferase; Streptomyces spheroides; novobiocin; TylF superfamily; crystal structure
Introduction
The process of methylation has diverse roles in biology, including chromatin regulation, gene
silencing, signal transduction, protein repair, protein partitioning and biosynthesis.1 Particular
interest surrounds the mammalian O-methyltransferases (OMTs) as they are the targets of
therapeutic agents designed to treat Parkinson's disease.2 More recently, OMTs have attracted
considerable interest on account of their roles in decorating antibiotics3; 4;5 and other
therapeutic agents6 and their potential application for creating chemical diversity in a range of
compound classes.
In the majority of methyltransferases, S-adenosyl-L-methionine (SAM) is the methyl donor,7
although there are a number of examples where a cobalamin (vitamin B12) cofactor is used to
mediate methyl transfer from a variety of donor molecules to the substrate.8;9 The substrates
of both types of enzyme range in size from small molecules through to DNA and proteins, and
methylation at carbon, oxygen, nitrogen, sulphur or even halides is possible.10; 11 Equally
diverse are the methyltransferases that perform these reactions.1 Analysis of their structures
indicates that the majority are fundamentally similar, having core folds reminiscent of the
canonical Rossman nucleotide binding fold12 with a central, mainly parallel, β-sheet flanked
on both sides by α-helices. Nevertheless, in many cases, these cores have been embellished
with additional structural elements tailored to accept a plethora of substrates. The structures
seen so far can be loosely grouped by topology into five classes (I – V).1 However, even within
a class, the sequence similarity can be as low as 10%. In the SAM-dependent enzymes, the
only residues that are loosely conserved lie in the N-terminal region of the core fold and
comprise a glycine-rich sequence (referred to as motif I) that interacts with the amino acid
portion of SAM, and an acidic loop (denoted motif II), which interacts with the ribose
hydroxyls.7
The aminocoumarin antibiotics target the essential bacterial enzyme DNA gyrase; they bind
to the B subunit and are competitive inhibitors of the ATPase reaction.13 The three main
compounds novobiocin, clorobiocin and coumermycin A1 share common structural features,
namely an aromatic acyl component (ring A), a 3-amino-4,7-dihydroxycoumarin moiety (ring
B) and an L-noviosyl sugar (ring C). The biosynthesis of novobiocin (Fig. 1) requires three
methylation steps which are performed by three distinct SAM-dependent methyltransferases:
(1) NovO (subunit molecular weight 25 kDa) methylates at position C8 of the aminocoumarin
ring, (2) NovU (subunit molecular weight 46 kDa) introduces a second methyl group at C5 of
the noviose sugar prior to reduction of the keto group at C4 and transfer of the sugar moiety
to the aglycone moiety, and (3) NovP (subunit molecular weight 30 kDa) methylates the 4-OH
of the noviosyl group immediately after the glycosyl transfer step and represents the
penultimate step of the whole pathway.14 This latter methyltransfer is common to both the
clorobiocin15 and coumermycin A116 pathways, being catalysed by the enzymes CloP and
CouP, respectively. In the case of coumermycin A1, the reaction occurs twice since it has two
noviose sugars, one at each end of the molecule.4; 17 The final step of novobiocin biosynthesis,
which is unique to this pathway, is the transfer of a carbamoyl group to the 3-OH by NovN.18
Methylation of an antibiotic can have both indirect and direct effects on its potency. Firstly,
methylation will increase the lipophilicity of the antibiotic, facilitating its absorption across
membranes and leading to elevated intracellular concentrations. Secondly, methyl substituents
may form important hydrophobic interactions with the target. Crystallographic studies on
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novobiocin complexes of DNA gyrase19; 20; 21 have shown that the decorated novoise sugar
(ring C) is responsible for the majority of the interactions with the target enzyme and that the
4-methoxy group itself partially occupies a hydrophobic pocket formed by the side-chains of
residues Ile78 and Val120 of E. coli GyrB. Although no data are available on novobiocin
lacking the 4-methoxy group, the equivalent desmethylated form of clorobiocin showed only
5% of the antibacterial activity of the parent compound against Bacillus subtilis22 and a 25-
fold increase in the IC50 value required to inhibit supercoiling in E. coli DNA gyrase.23
Previous characterisation of NovP has shown it to have low, but measurable, in vitro activity,
with kcat = 0.400 ± 0.006 min−1 and KM = 9.5 ± 3 µm.18; 24 Studies with NovP and its orthologue
CloP, have shown that both enzymes are capable of methylating unnatural substrates.25; 26 The
crystal structure of NovP presented here may provide explanations for these phenomena and,
moreover, identify ways of manipulating the enzyme towards enhancing its in vitro activity
and substrate promiscuity.
Results
Overall structure of NovP
The crystal structure of NovP was determined at 1.4 Å resolution. Of the 262 residue native
sequence, a total of 242 amino acids were present in the final model: the first 13 residues (plus
the 20-residue N-terminal His-tag which was not cleaved prior to crystallization), and a surface
loop comprising residues 39–45 were not modelled because of insufficient electron density.
Only four side-chains were not fitted (Asp14, Arg159, Lys241 and Arg262), and seven were
modelled in two alternate conformations (Met22, Asp165, Thr189, Met226, Glu237, Ile249,
Arg260).
The NovP monomer consists of a single globular α/β domain with approximate dimensions 53
× 46 × 37 Å (roughly corresponding to the horizontal, vertical and into plane dimensions of
the molecule as viewed in Fig. 2). As expected, the topology is reminiscent of the classical
Rossmann nucleotide binding fold.12 The central, predominantly parallel, β-sheet is comprised
of seven strands with connectivity −1x, −1x, 3x, 1x, 2x, −1, using the nomenclature of
Richardson,27 which is flanked on both sides and at the C-terminal end by a total of ten α-
helices and two 310 helices. This is consistent with a class I methyltransferase fold which is
described as “a doubly wound open αβα sandwich”.1 Crystallization of NovP was strictly
dependent on the presence of S-adenosyl-L-homocysteine (SAH), the desmethylated co-
substrate, and this was clearly visible in the structure, positioned at the C-terminal end of the
β-sheet, which is the expected location for the nucleotide binding site in Rossmann fold
proteins.
Sequence homologues of NovP
The reaction catalysed by NovP in novobiocin biosynthesis is common to the coumermycin
A1 and clorobiocin biosynthetic pathways. Although there are structural differences in the
methyl acceptors, these are not proximal to the 4-OH of the noviosyl moiety (N.B. in all cases
the 3-OH is not substituted at this stage in the respective biosynthetic pathways). It is no
surprise, therefore, that in a BLAST search (http://www.expasy.ch/tools/blast/) with the NovP
protein sequence, CouP and CloP are the top hits with respectively 89.1% and 84.1% amino
acid sequence identity to NovP. In fact, all three enzymes belong to the TylF superfamily
(PF05711), as defined in the PFAM database (http://pfam.sanger.ac.uk/),28 which currently
contains 69 sequences. These are found across 47 species from 7 phyla and, with the exception
of two sequences from the eukaryote Trypanosoma cruzi, they are restricted to the bacterial
kingdom, with almost two thirds, including TylF and the three aminocoumarin biosynthetic
enzymes, being found in Actinobacteria. These latter four sequences, together with
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representative sequences from the other six phyla, are aligned in Fig. 3a. TylF itself is
responsible for the methylation of macrocin to produce the antibiotic tylosin in Streptomyces
fradiae3 and shares 48.9% amino acid sequence identity with NovP. As with NovP, TylF
catalyses O-methylation of a deoxysugar, but at the 3- rather than the 4-position; this is the
final and rate-limiting step in tylosin biosynthesis.29; 30 To date, NovP provides the only
representative crystal structure for the superfamily. Sequence comparisons suggest that a
number of features that are characteristic of the NovP structure are found throughout the TylF
superfamily (Fig. 3a).
Structural homologues of NovP
The structures of methyltransferases are well represented in the Protein Data Bank (PDB),31
accounting for approximately 1% of all entries: a simple search of the PDB (as of June 1st
2009) based on the methyltransferase Enzyme Classification number (EC 2.1.1) retrieves 658
structures, which reduces to a non-redundant set of 247 after filtering out multiple copies of
those with similar sequences (>90% identity). Close structural homologues were identified by
submitting the NovP structure to the DALI server
(http://ekhidna.biocenter.helsinki.fi/dali_server/),32 which returned 386 hits with Z scores of
at least 10.0, reducing to a non-redundant set of 115 after filtering; still a substantial number.
For the purposes of the following discussion, comparisons were mostly limited to selected
enzymes with Z-scores exceeding 15.0. These are summarised in Table 1 and a structure-based
sequence alignment versus NovP is shown in Fig. 3b. These are all OMTs and they belong to
the small-molecule methyltransferase family7 and have catechol-based substrates. Despite
their structural similarities to NovP, at the amino acid sequence level, they only share identities
in the range 11–14%. On the whole, the structural alignments of these enzymes with NovP are
good, and where SAM/SAH ligands are present, they superpose well. However, for the first
60 or so residues of NovP (i.e. prior to α3), the structural alignment is poor (Fig. 4a), but this
is not unexpected since these regions are generally quite variable in the small-molecule
methyltransferases.7 In addition, beyond the aminocoumarin biosynthetic enzymes in the TylF
superfamily, the sequence conservation in this N-terminal region is poor (Fig. 3a), and therefore
it is possible that there is also considerable structural variation for this region even within the
superfamily.
The only other sugar OMT for which there is an X-ray structure is RebM (PDB accession code
3BUS), which is involved in the biosynthesis of the antibiotic rebeccamycin in Lechevalieria
aerocolonigenes.5 In common with NovP, methylation occurs at the 4-OH of the sugar.
However, despite the substrate similarity, RebM is not amongst the closest structural
homologues to NovP (Fig. 4b) with a DALI Z score of 10.1; this may be in part because they
are likely to function by different mechanisms, as described below.
NovP is a homodimer
There is a single copy of the NovP protomer in the asymmetric unit, although analysis of crystal
contacts using the Protein Interfaces, Surfaces and Assemblies server (PISA) at the European
Bioinformatics Institute (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html)33 indicates that
there may be a biologically relevant dimer, which is generated by the crystallographic 2-fold
axis. The resultant dimer is relatively elongated and the interface buries some 856 Å2 of protein
surface per subunit, which amounts to approximately 8% of the monomer solvent accessible
surface and mainly involves residues from helices α1 and α7 (Fig. 3 and Fig. 5). This putative
dimer is distinct from the relatively compact dimer seen in several of the structurally related
OMTs, such as the Synechocystis OMT (SynOMT, PDB code 3CBG)34 and the alfalfa caffeoyl
CoA OMT (CCoAOMT, PDB code 1SUS),35 where the buried surface in these is more
extensive (1684 and 1903 Å2, respectively), and involves a completely different face of the
molecule (Fig. 5). The presence of a NovP dimer in solution was confirmed using size exclusion
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chromatography. The main NovP fraction eluted at a size of approximately 66 kDa,
corresponding closely to the value of 64.2 kDa expected for a His-tagged dimer. There was no
peak that could be attributed to monomer. Given that the majority of the interactions are
hydrophobic, and therefore non-specific, it is difficult to predict with certainty whether this
interface is a common feature of the TylF superfamily.
Nevertheless, with the exception of the amino acid at the equivalent of position 14 in the NovP
sequence, the interface residues are all conserved in CouP and CloP, strongly suggesting this
dimer is also a feature of these two proteins. TylF has already been shown to exist as a
homodimer in solution,29; 30 but since only around half of the NovP dimer interface residues
are conserved in TylF, the existence of an equivalent dimer in TylF would seem less certain.
The conservation of the interface residues in the representative sequences from the other six
phyla is relatively low and thus NovP-like dimers would seem much less likely for these
proteins. Indeed, for MtfB from Microscilla marina ATCC 23134, this type of dimer could
not exist since it completely lacks the equivalent of helix α1 of NovP (Fig. 3a). To our
knowledge, with the exception of NovP and TylF, the oligomeric states of other TylF
superfamily members have not been established to date.
The SAM/SAH binding site
In common with other Class I methyltransferases, the SAH ligand in NovP adopts an extended
conformation. It is tightly bound, with virtually every potential hydrogen-bonding group of
the ligand interacting directly with the protein (Fig. 6); there are also a significant number of
non-bonded interactions. The NovP sequence contains recognisable motifs I and II that are
typical of SAM-dependent methyltransferases. Motif I, the 'glycine rich sequence' lies between
β1 and α4 and forms the expected interactions with the amino acyl portion of SAM via Glu92
and Gly94. There is also a further interaction between Trp96 and the ribose. Motif II, the 'acidic
loop', which lies at the C-terminal end of β2, forms the expected interactions with the ribose
hydroxyls via Asp122. The sequences of motifs I and II are well conserved in the TylF
superfamily (Fig. 3a).
In the close structural homologues of NovP, the nucleotide is bound in a solvent accessible
surface cleft with, at most, one or two side-chains gating exchange of the co-substrate with the
desmethylated co-product. In NovP, the bound SAH is almost completely buried, such that
only the exocyclic N6 amino group of the adenine ring and the sulphur atom are accessible to
bulk solvent (Fig. 2). Clearly for turnover, SAH/SAM exchange is required, but this would
necessitate significant conformational changes. Inspection of protein backbone indicates that
the majority of the polypeptide between β2 and β3, specifically residues 126–151 inclusive,
form a largely helical sub-domain that forms a lid over the co-substrate binding site. This region
appears as an insertion in the structure-based sequence alignment of NovP with close structural
homologues (Fig. 3b). In fact, the residues immediately before and immediately after the lid
are close together in space (Cα - Cα separation 6.2Å), such that deletion of the lid would very
likely have little effect on the rest of the structure. Although the lid appears to mediate SAH/
SAM interchange, only two amino acids, Gly126 and Pro128, interact directly with the co-
substrate. They form van der Waals interactions with the ribose and adenine moieties,
respectively and thus, presumably, the lid cannot directly sense the methylation status of the
co-substrate. Sequence comparisons suggest that the lid is a common feature of all members
of the TylF superfamily (Fig. 3a); it is notable that Gly126 and Pro128 are well conserved,
suggestive of functional roles, for example, the inherent flexibility of the Gly may be important
for conformational changes in the lid. Asp128 is quite well conserved and, in the NovP
structure, its side-chain hydrogen bonds to the backbone amides of Tyr200 and Glu201, and
thus may have a role in maintaining the closed conformation of the lid. Elsewhere, the lid
sequences are poorly conserved, although, in the alignment shown in Fig. 3a, the lid regions
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are of a similar length, with the exception of that from Herpetosiphon aurantiacus, which is
fifteen residues longer than that of NovP.
Analysis of temperature factors reveals that the lid is more mobile than the rest of the NovP
structure, consistent with the hypothesis that it gates access to the SAM site (residues 126–151
inclusive have average main-chain and side-chain temperature factors of 20.5 and 24.7 Å2,
respectively, as compared to the values of 14.0 and 17.7 Å2, respectively, for the rest of the
protein). Moreover, the presence of four Gly residues in this sub-domain may give it increased
flexibility. The lid regions of the two monomers within the putative dimer lie on the same face
of the assembly. However, since they are not close to the dimer interface itself, they probably
function independently.
In the initial characterisation of NovP, the in vitro methyltransferase activity of the enzyme
was reported to be exceedingly low,18 taking over 2 minutes per reaction. It is tempting to
speculate that turnover is, at least in part, rate-limited by SAH/SAM interchange, which clearly
necessitates a large conformational change. However, thermally-driven domain motions
generally occur on the micro- to milli-second timescale,36; 37 and therefore lid movement alone
may not fully account for the poor activity. Nevertheless, in these cases, domain motions
involve relatively simple and concerted movements of groups of atoms along similar
trajectories; perhaps in NovP a more complex, and relatively time-consuming, conformational
change is necessitated to expose the co-substrate binding site. It is possible that protein-protein
interactions with other pathway enzymes play important roles in upregulating the activity of
NovP in vivo, perhaps assisting the opening of the lid which would otherwise be firmly closed;
in the crystal structure there are nine hydrogen bonds between the lid and the rest of the protein.
Likely candidates include the enzymes catalysing the steps immediately before (i.e. the
glycosyl transferase NovM) or after (i.e. the carbamoyltransferase NovN) the NovP step.
Moreover, such protein-protein interactions may be required to channel the intermediates
between successive active sites in the pathway to prevent their loss into the cytoplasm, where
they could exert their toxic effects.38 However, to date, there is no evidence either for or against
these protein-protein interactions.
Several of the structural homologues have an extended loop between the equivalents of β5 and
α10 in NovP (Fig. 3b, Fig. 4 and Fig. 5). This has been described elsewhere as the 'insertion
loop' and plays a role in substrate binding.35; 39 Superpositions of these structures with that of
NovP show that these insertion loops overlap with α5 of the lid region of NovP (Fig. 4 and
Fig. 7), suggesting that these two structural features are mutually exclusive in a given enzyme.
Indeed, all TylF superfamily members have very short loops here (Fig. 3a). In NovP, this loop
contains a CPPC sequence and, in the structure, the two Cys residues are linked by a disulphide
bridge (Fig. 2–Fig. 5 and Fig. 7). Disulphide bridges are unusual in cytoplasmic proteins and
it is conceivable that this is an artefact brought about by the prolonged exposure of the protein
to aerobic conditions. Indeed, the NovP crystals took up to one month to grow.40 The
observation that only the second of the two Cys residues is conserved in the TylF superfamily
(Fig. 3a) would suggest that the disulphide bridge is neither functionally nor structurally
important. However, given the proximity of the disulphide bridge to the active centre then,
perhaps its formation may, for example, distort the metal binding site and thereby to some
extent account for low in vitro enzyme activity.
The active site and putative mechanism
As mentioned in the previous section, despite being almost completely buried, the SAH sulphur
atom is solvent exposed (Fig. 2). In fact, it sits at the end of a well-defined channel leading to
bulk solvent; several of the residues lining this channel are well conserved across the TylF
superfamily (Fig. 3a). This is undoubtedly the route by which the substrate,
desmethyldescarbamoyl novobiocin (DDN), approaches the co-substrate. Indeed, when SAM
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is modelled in place of the SAH, the strongly electrophilic methyl group would be the first
atom of the co-substrate that an approaching substrate molecule would encounter. The methyl
group lies approximately 11 Å from the mouth of the channel. The outer section of the channel
is approximately 8–10 Å across and then becomes constricted some 5 Å from the methyl group,
being approximately 4–6 Å across thereafter. One side of the channel is delineated by the lid
region, and it seems likely that it plays a role in binding the substrate and guiding it into the
active site. The residues lining the channel are strictly conserved between NovP, CouP and
CloP, with the exception of that at position 146 (NovP sequence numbering), which is in the
lid region (Fig. 3a). This is an Arg in both NovP and CouP, and a His in CloP. Rings B and C
(see Fig. 1a) of the methyl acceptors for these three enzymes are identical apart from the C8
of ring B, being methylated for NovP and CouP substrates and chlorinated for the CloP
substrate. This raises the possibility that the amino acid at position 146 may have some role in
binding ring B, in particular the substituent at C8. Nevertheless, there are precedents for both
Arg and His interacting with chlorine atoms in halogenated compounds.41 Beyond the
aminocoumarin biosynthetic enzymes, the conservation of the residues lining the active site
channel is less marked, for example in TylF, of the 20 residues that line the channel, only 11
are conserved (Fig. 3a), with 4 of these being the Asp residues that are implicated in the
mechanism described below (Fig. 8). Although the sugar moieties of the NovP and TylF
substrates are both β-linked 6-deoxy sugars, they are quite dissimilar: (i) they have the opposite
configuration i.e. L-noviose for NovP, and 6-deoxy-2-O-methyl-D-allose for TylF, (ii) they
have different substitutions, and (iii) the hydroxyl groups to be methylated are at the 4 position
and equatorial for NovP, and at the 3 position and axial for TylF (Fig. 1). Therefore, the
relatively poor sequence conservation in the active site channels of NovP and TylF is not
altogether unexpected. As the result of the substrate docking experiments described below, the
side-chain of Trp58 was identified as a potential hydrogen bonding partner to the ring oxygen
of noviose (Fig. 8). This is conserved in roughly half of the TylF sequences and could be
indicative of a substrate containing a methyl acceptor sugar with similarities to the β-linked L-
noviose of novobiocin. For instance, the sugar moieties in elloramycin42 and nogalamycin43
are both β-linked L-sugars and the Trp is conserved in their respective OMTs; the Trp is not
conserved in the OMTs for tylosin and chalcomycin,44 which act on β-linked D-sugars, nor is
it conserved in the OMT for chromomycin A3,45 which acts on an α-linked D-sugar. Since
functional data on many of the TylF superfamily proteins is rather scant, it is difficult to make
broader comparisons.
It is conceivable that the disordered loop between α1 and α2 of NovP (residues 39–45) could
impinge on the mouth of the substrate binding channel (Fig. 2), and perhaps play a minor role
in substrate binding. By contrast, it seems unlikely that the disordered N-terminus would have
any effect on substrate binding since it lies on the opposite face of the molecule to the active
site. The closest structural homologues to NovP are either proven or putative metal-dependent
OMTs and almost exclusively employ the side-chains of two Asp and a single Asn residues to
bind the metal, which is usually magnesium. The two Asp residues are structurally conserved
in NovP (residues 196 and 223), but the Asn is replaced by a further Asp (residue 224). It would
seem highly probable that this triad of residues also represents a metal binding site in NovP;
its significance is supported by the juxtaposition of this site to the projected position for the
methyl donor group of SAM, as well as the strict conservation of these residues in the TylF
superfamily (Fig. 3a). Indeed, TylF itself has previously been shown to be a divalent metal-
dependent enzyme, being active with Mg2+ ions, as well as with Mn2+ and Co2+ ions.29; 30;
46 However, no evidence for metal ions is present in the NovP crystal structure and, moreover,
no density for metal ions was apparent after crystallisation or soaking crystals with MgCl2
(data not shown). It is conceivable that metal binding is co-dependent on substrate binding;
the majority of the homologous structures that contain metal ions in their active sites also
contain bound substrates, products or inhibitors. Although the presence of divalent metal ions
was not explicitly reported in the assay conditions used for the biochemical characterisation
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of NovP,18 both 10 mM MgCl2 and MnCl2 were tested in initial experiments, but these did not
have a measurable effect on activity (Freel Meyers, personal communication). This suggests
that the availability of these metal ions is not rate-limiting in vitro, even when they are not
specifically added to the assay. Curiously, the addition of 10 mM CaCl2 drastically reduced
the level of product formation (Freel Meyers, personal communication). With hindsight, the
inhibitory effect of calcium ions is likely due to competition with the presumed trace quantities
of the preferred divalent metal ions.
In general, methyltransferase reactions involve the direct transfer of the methyl group to
substrate in an SN2-like mechanism. This process requires that the substrate be deprotonated
before, at the same time as, or after methyl transfer. In metal-independent OMTs such as
chalcone OMT, isoflavine OMT47 and RebM,5 a His residue deprotonates the hydroxyl. The
structural data presented above together with comparisons with related structures, and the
biochemical data for TylF,29;30; 46 strongly support the hypothesis that NovP is a metal-
dependent enzyme, and that the metal is coordinated via the strictly conserved residues,
Asp196, Asp223 and Asp224. The metal ion may have roles in both the binding of the substrate
and polarising the 4-OH to facilitate, rather than effect, its deprotonation. The closest structural
homologues to NovP (Table 1) appear to employ a nearby Lys residue to deprotonate the
substrate hydroxyl. The equivalent residue in the NovP sequence is actually Leu199 (Fig. 3b).
However, the protein backbone directs the side-chain of Leu199 away from the active site.
Instead, the side-chain of the previous residue, Asp198, points into the active site and would
appear to be ideally placed to act as the general base (Fig. 7). This alternative backbone
conformation may be a consequence of a single residue insertion in the β4 - α9 loop of NovP
relative to its structural homologues. The temperature factors for this loop (residues Asp196-
Tyr200) are comparable to the overall average for the rest of the protein (minus the lid),
indicating that this is not a particularly mobile region, and is therefore likely to be preconfigured
for catalysis. Asp198 is also strictly conserved in the TylF superfamily, thereby supporting its
proposed importance. Moreover, in a superposition with RebM, the side-chain of Asp198 in
NovP occupies the equivalent position to that of His140, the catalytic base of RebM (Fig. 7b).
The proposed NovP mechanism is illustrated in Fig. 8.
Since the lid region constitutes one face of the substrate-binding channel it seems plausible
that this would be in place before the substrate binds, in other words, SAM would bind first.
After methyltransfer, either product could leave first, although it would seem more likely that
SAH would be the last to leave as it is tightly bound in the crystal structure. This is consistent
with the ordered Bi Bi mechanism reported for TylF.29; 30
It is not possible to draw any firm conclusions from a comparison of the architectures of the
NovP and RebM active sites, as it is difficult to predict where the substrate would bind for the
latter because there is insufficient space adjacent to His140 to accommodate the substrate in
the crystal structure.5 Access to His140 in RebM is occluded by (i) a 22 residue insertion
relative to NovP in the β5 - α10 loop (equivalent position to the insertion loops described
above), (ii) a 49 residue insertion in the β6 - β7 loop, and (iii) the N-terminus (which contains
a short α-helix in one of the two copies of the monomer in the asymmetric unit) (Fig. 4b). At
least one of these elements would need to move to admit the substrate; an analysis of
temperature factors in the RebM structure indicates that the N-terminus is the most mobile.
Substrate docking
Attempts were made to obtain crystals of additional NovP-ligand complexes, using the product
(descarbamoyl novobiocin) and a substrate analogue (methylrhamnoside), but we did not have
sufficient quantities of substrate for these experiments. Co-crystallisation and soaking
experiments were performed for these compounds in the presence of either SAH or SAM, both
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with and without magnesium ions (MgCl2); unfortunately, we were not successful (data not
shown).
In order to generate a model of the quaternary complex formed between NovP, SAM, Mg2+
and DDN, we resorted to in silico docking using AutoDock4.48; 49 The 'receptor' consisted of
the desolvated protein plus SAM and a Mg2+ ion coordinated by the side-chains of Asp196,
Asp223 and Asp224 and was prepared as described in Materials and Methods. The ligand was
allowed full flexibility and, for each simulation, 100 runs were evaluated. Productive binding
modes were identified as poses that placed the 4-OH of the noviose moiety of DDN within 4
Å of the methyl group of SAM. When the situation prior to reaction was simulated, i.e. when
the 4-OH is still protonated and Asp 198, the general base, is deprotonated, there were only 3
poses that satisfied this condition, with the best docking energy being −8.68 kJ mol−1. However,
when the situation after the deprotonation of the 4-OH by Asp 198 was simulated, there were
98 poses that satisfied this condition, with the best docking energy being −15.88 kJ mol−1.
Thus, mimicking an 'activated' enzyme-substrate complex is a much more efficient means of
identifying productive binding modes. This approach has been used previously with rat liver
catechol OMT.50 The 98 productive poses were sorted into 12 clusters based on similarity, and
the conformation of the lowest energy pose from each cluster is displayed in Fig. 9. It is clear
that the conformation of the noviose moiety (ring C) is essentially the same in all 12 poses,
with all the interactions shown in Fig. 8 being present. This is not surprising as ring C occupies
the relatively constricted inner section of the channel where it has little conformational
freedom. The position of the aminocoumarin moiety (ring B) is more variable, but nevertheless
the conformations seen fall into roughly 4 clusters. Again, this is to be expected because ring
B is located in the outer part of the channel and thus has more conformational freedom. Also
shown in Fig. 9 is the position of Arg146 in the lid region. The side-chain of this residue is
directed towards the aminocoumarin ring, suggesting that it could have a role in binding this
moiety, in particular the substituent at C8, as discussed earlier. The prenylated
hydroxybenzoate moiety projects beyond the substrate channel and thus it takes up a variety
of conformations and generally makes very little contact with the protein. It would therefore
seem likely that NovP could tolerate quite substantial changes to the ring A substituent without
compromising its ability to methylate the noviose moiety; this has already been demonstrated
experimentally.25
Conclusion and Summary
The structure of NovP from Streptomyces spheroides is the first representative structure of a
SAM-dependent O-methyltransferase from the TylF superfamily. Although it has many close
structural homologues in the PDB, it displays a number of differences that are likely to be
characteristic features of the TylF superfamily. NovP forms a novel elongated dimer mediated
largely by hydrophobic interactions. Rougly half of the NovP dimer interface residues are
conserved in TylF, so it is possible that the dimer previously observed for TylF29; 30 may have
a similar arrangement. Comparisons with related structures support a divalent metal-dependent
mechanism using a 3-Asp metal-binding site and a further Asp as a general base. Moreover,
the strict conservation of these four residues in the TylF superfamily, and the observation that
TylF itself is also divalent metal-dependent29; 30; 46 further strengthens this hypothesis. Access
to the co-substrate binding pocket is mediated by a 26-residue helical sub-domain, denoted the
lid, which also forms one face of a funnel-shaped substrate access channel. Using in silico
docking we have provided plausible models for the quaternary complex formed between NovP,
SAM, Mg2+ and the substrate desmethyldescarbamoyl novobiocin.
Although it is not possible to state definitively due to the vagaries of sequence annotations, it
seems probable that most, if not all, TylF superfamily members are sugar OMTs and, certainly
within the Streptomycetes, they are implicated in the biosynthesis of several glycosylated
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therapeutic agents e.g. tylosin,3 elloramycin42 and chromomycin A3;51 in all of these examples
the substrates are sugars attached to bulky aglycone moieties. Thus, the conclusions drawn
from the NovP structure could have broader implications for the biosynthesis of glycosylated
microbial natural products in general. The lid region, which also appears to be a general feature
of the TylF superfamily, could partially account for the poor in vitro activity of NovP, since
large, potentially rate-limiting, conformational changes would be required for SAM/SAH
interchange. It is also possible that NovP is subject to product inhibition, as has been suggested
previously;52 both substrate and product inhibition have also been reported for TylF.29; 30;
46 The physiological role of the lid is unclear, but it may function to sequester SAM from other
competing metabolic pathways in preparation for the arrival of DDN. Alternatively, NovP may
represent a control point in the biosynthetic pathway and, by regulating its activity through
some mechanism involving the lid, the cell could limit the production of potentially cytotoxic
compounds. In this regard, it is notable that in the biosynthesis of tylosin,3 elloramycin42 and
chromomycin A3,51 the TylF superfamily member is either the terminal or penultimate enzyme
in the pathway and, therefore, the reactions they catalyse are likely to have a significant effect
on the potency of the biosynthetic intermediate. In addition, TylF has been reported to represent
the rate-limiting step in tylosin production.29
Although the substrate promiscuity of NovP has not been fully explored, it will tolerate
modifications to ring A;25 the same is also true for CloP.26 These observations are consistent
with our models of the enzyme-substrate complex derived from the docking simulations, which
show that ring A projects beyond the substrate binding channel, and thus is unlikely to form
significant contacts with the protein. It seems probable that modifications to rings B and C are
less likely to be tolerated due to steric constraints within the substrate binding channel.
NovP clearly has potential as an enzyme for tailoring a variety of glycosylated compounds,
but its utility will be limited by poor in vitro activity and restricted substrate specificity. We
can potentially address both of these issues simultaneously through mutations to the lid sub-
domain; the most drastic mutation being a complete excision of this region (residues 126–151
inclusive). Comparisons with close structural homologues suggest that this deletion should not
disrupt the rest of the structure and would leave a solvent accessible SAM binding pocket and
a less constrained substrate binding site.
Materials and Methods
X-ray crystallography
Recombinant, N-terminally His-tagged Streptomyces spheroides NovP was purified and
crystallized, and the structure was solved using a combination of isomorphous replacement
with anomalous scattering (SIRAS) with manual building of the initial very noisy map and
data extrapolation to 1.0 A, as described previously.40; 53 The NovP structure was completed
by further rounds of restrained refinement and interactive model building. Positional and
anisotropic thermal parameters of the model were refined with REFMAC554 against a 1.4 Å
resolution native data set that was collected on beamline PX10.1 at the SRS (Daresbury),40;
53 and solvent molecules were automatically added using the ARP procedure.55 Model
building was performed using the program COOT56 with reference to SIGMAA-weighted57
2mFobs – DFcalc and mFobs – DFcalc Fourier electron density maps. This yielded a high
quality structure with final Rwork and Rfree values of 14.5% and 16.2%, respectively, and 96.6%
of the residues in the favoured regions of the Ramachandran plot with no outliers, as evaluated
by MOLPROBITY.58 A summary of the X-ray data, together with the contents and the
geometrical parameters of the final structure, is given in Table 2.
A difference electron density 'omit' map was generated for the SAH ligand using phases
calculated from the final model minus the SAH coordinates after simulated annealing (SA)
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refinement (Fig. 6). The SA refinement was performed from a starting temperature of 5000 K
after applying random shifts to the model ('shake' term set to 0.3) using PHENIX.59 All
structural figures were produced using PyMOL.60
Size exclusion chromatography
The oligomeric state of a sample of His-tagged NovP was analysed by gel filtration. Protein
was purified by nickel affinity chromatography as described previously40 and subsequently
buffer-exchanged into 50 mM Tris-HCl, 200 mM NaCl at pH 8.0. Approximately 2 ml of
sample was then loaded onto a Superdex 75 16/60 column (GE Healthcare) at a concentration
of approximately 10 mg ml−1 and eluted with the same buffer at a flow rate of 1 ml min−1. The
column was calibrated using a low molecular weight calibration kit (GE Healthcare) containing
the following standards: albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25
kDa), ribonuclease A (13.7 kDa) and dextran blue (2,000 kDa).
Substrate docking
Docking simulations were carried out using the program AutoDock448 through the
AutoDockTools graphical user interface.49 The ‘receptor’ consisted of the desolvated protein
plus SAM and a Mg2+ ion. This was prepared by replacing the SAH of the crystal structure
with SAM and inserting a Mg2+ ion adjacent to the side-chains of Asp196, Asp223 and Asp224
using the superposed structures shown in Table 1 as a guide. The conformations of the three
Asps were adjusted manually in order to optimise interactions with the Mg2+ ion. The resultant
complex was subjected to 300 cycles of maximum likelihood energy minimization using
CNS61 prior to docking (with the 'Wa' term set to zero). During docking, the receptor was
treated as a rigid entity with the exception of the side-chains of Asp198, the putative active site
base, and Trp58, which appeared to be ideally placed to hydrogen bond to the ring oxygen of
the noviose moiety (this had been established from previous trial simulations). A random
starting position was chosen for the substrate (DDN) in which all single bonds were allowed
to rotate. Searches were performed using a Lamarckian Genetic Algorithm within a cube of
edge 26 Å with a grid spacing of 0.375 Å that encompassed the substrate binding channel of
NovP. Simulations consisted of 100 runs, each with a population size of 150 and 25,000,000
energy evaluations. A total of 27,000 generations were analyzed, with only a single
conformation surviving to the next generation. Three hundred local search iterations were
carried out for each run. The resulting substrate conformations were clustered on the basis of
their similarity with an rms tolerance of 2 Å. Docked poses were filtered automatically:
‘productive’ binding modes were detected by selecting poses that placed the 4-OH of the
noviose moiety of DDN within 4 Å of the methyl group of SAM. The simulation was performed
twice with the above parameters and it was assumed that the first step in the reaction is
deprotonation at 4-OH of the noviose moiety. For the first simulation, the 4-OH was protonated
and Asp198 was deprotonated, in order to model the enzyme-substrate complex prior to the
reaction. For the second simulation, the situation after proton transfer from the 4-OH of noviose
to Asp198, but prior to the methyltransfer step was modelled. Thus, in this case, the 4-OH was
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CCoAOMT alfalfa caffeoyl CoA OMT
PDB Protein Data Bank
SA simulated annealing
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The structures of novobiocin and tylosin. (a) Novobiocin is an aminocoumarin antibiotic
comprised of three ring systems, which are synthesised separately. The three methylation steps
are indicated together with the final O-carbamoylation by NovN. NovO and NovU act during
the synthesis of rings B and C, respectively. NovP methylates the 4-OH group of the L-noviose
moiety when the antibiotic is almost fully formed; this represents the penultimate step of the
whole pathway. The substrate for NovP, desmethyldescarbamoyl novobiocin (DDN) bears
only hydroxyl groups at positions 3 and 4 of the noviose sugar. Rings B and C are identical in
the substrates of the NovP orthologs CouP and CloP, with the exception that in the substrate
for CloP, the C8 position of ring B is chlorinated rather than methylated. (b) Tylosin is a
macrolide antibiotic. TylF performs the terminal step of the pathway by methylating the 3-OH
group of 6-deoxy-2-O-methyl-D-allose.
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Stereoviews showing the overall structure of NovP. (a) Backbone trace with every tenth residue
labelled. (b) Cartoon representation with important residues shown in stick mode. (c) Molecular
surface representation illustrating the solvent inaccessibility of the SAH and the shape of the
active site channel. Throughout, the lid region is coloured red, and the disordered loop (residues
39–45 inclusive, which have been modelled into energetically favourable conformations) is
shown in cyan. The 3-Asp putative metal-binding site is coloured green and Asp198, the
proposed general base, is shown in blue. The disulphide bridge residues, Cys228 and Cys231,
are coloured magenta. The SAH ligand is shown in stick representation and the position of the
sulphur atom is indicated by an asterisk.
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Multiple protein sequence alignments versus NovP. For both panels the alignment is displayed
using ESPript.62 Strictly conserved residues are highlighted with red shaded boxes, and well
conserved residues are boxed with the predominant residues coloured red. Secondary structure
elements for NovP are shown above the alignment, where α = α helix, β = β strand, η = 310
helix, TT = β turn. Residues that are postulated to be involved in cation binding in NovP are
marked by green triangles; Asp198, which is thought to act as a general base during the
methyltransfer reaction, is indicated by the single blue triangle. Residues that are hydrogen
bonded to SAH are indicated by dark blue letters where “S” refers to a side-chain interaction
and “M” refers to a main-chain interaction. Although Asp196 is marked by a green triangle,
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indicating a role in cation binding, it also hydrogen bonds to SAH. Residues that form the NovP
dimer interface are marked with asterisks, and these are coloured red for those residues that
form hydrogen bonds. Other features of the NovP structure are labelled, i.e. the lid region,
regions of disorder, the disulphide bridge, and the SAM-dependent methyltransferase motifs
I and II. (a) Alignment of NovP with selected sequences from the TylF superfamily. The first
four are from Streptomycetes (phylum Actinobacteria). They are: NovP from S. spheroides
(NovP_S.sph), CouP from S. rishiriensis (CouP_S.ris), CloP from S, roseochromogenes subsp.
oscitans (CloP_S.ros), and TylF from S. fradiae (TylF_S.fra). The remainder are representative
sequences from the other six phyla which constitute the TylF superfamily, where the prefix
"Hypo" indicates an uncharacterised or hypothetical protein. They are from: Bacillus
anthracis (Hypo_B.ant; phylum Firmicutes), Herpetosiphon aurantiacus ATCC 23779
(Hypo_H.aur; phylum Chloroflexi), Trypanosoma cruzi (Hypo_T.cru; phylum Euglenozoa),
Synechococcus sp. (strain JA-3-3Ab) (Hypo_S.sp.; phylum cyanobacteria), Rhodospirillum
rubrum (Hypo_R.rub; phylum Proteobacteria) and Microscilla marina ATCC 23134
(MtfB_M.Mar; phylum Bacteroidetes). The magenta letters below the alignment indicate
residues that delineate the substrate access channel, where "N" refers to those adjacent to the
expected position of the noviose sugar (as predicted by the docking simulations), "A" refers
to those adjacent to the expected position of the aminocoumarin ring, and "B" refers to the
single residue, Trp58, that lies adjacent to both moieties. (b) Structure-based multiple sequence
alignment of Streptomyces spheroides NovP (NovP_S.sph) with selected O-methyltransferase
sequences for which there are crystal structures. Shown are the sequences from rat
(COMT_R.nor),50 Synechocystis sp. strain PCC 6803 (SynOMT_S.sp),34
Mesembryanthemum crystallinum (PFOMT_M.cry),39 Leptospira interrogans
(LiOMT_L.int),63 Bacillus cereus (BcOMT2_B.cer)64 and Medicago sativa
(CCoAOMT_M.sat).35 These are also summarised in Table 1. The initial alignment was
generated using EXPRESSO65 and subsequently adjusted manually with reference to the
superposed structures. Indicated below the alignment is the N-terminal region of poor structural
alignment (which includes helix α1), and the insertion loop that occurs in some of the structural
homologues, but not NovP itself. Note that, Asp198, the putative general base (blue triangle),
appears to be well conserved in the structural homologues of NovP. However, in these
structures the protein backbone directs the Asp side-chain away from the active site. Instead,
the side-chain of the next residue, a Lys in all but NovP, points into the active site and functions
as the base. This is indicated by the yellow triangle shown below the alignment. This difference
in main-chain conformation may be a consequence of the single residue insertion at the N-
terminus of helix α9 in NovP.
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Stereoviews showing superpositions of NovP with structural homologues. (a) Comparison of
NovP (green) with two metal-dependent OMTs: COMT (red; PDB code 2CL5) and
CCoAOMT (blue; PDB code 1SUS). (b) Comparison of NovP (green) with the metal-
independent enzyme RebM (red; PDB code 3BUS). The N-termini are highly variable between
all four structures shown until α3 of NovP (labelled) where they all converge. The protein
backbones are depicted in ribbon representation, except for their N-terminal helices, which are
highlighted in cartoon representation; the N-termini are marked with colour-coded labels. Also
shown in yellow are the SAH molecule and disulphide bridge of NovP. The view is equivalent
to that in Fig. 2.
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NovP forms a new type of dimer. (a) The relatively elongated NovP dimer as viewed down
the crystallographic 2-fold axis. The monomers are shown in cartoon representation with the
lid region in red and the disordered loop in cyan. Depicted as van der Waals spheres are the
bound SAH ligand (green with the sulphur atom in orange) and the disulphide bridge residues
(magenta). (b) The more compact SynOMT dimer (PDB code 3CBG). The yellow subunit is
shown in the equivalent orientation to the yellow subunit of NovP shown in (a). Note the
absence of a lid region; the much shorter loop that follows β2 is shown in red. The 13-residue
insertion relative to NovP that includes the so-called 'insertion loop' is shown in blue. This is
in the structurally equivalent position to the disulphide bridge of NovP. Rotating the SynOMT
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dimer by 45° around the horizontal axis gives a view approximately looking down the dimer
2-fold axis as shown in (c).
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Stereoview showing the co-substrate binding site of NovP. A simulated annealing 1.4 Å
resolution omit map for SAH contoured at 6σ is shown in blue; the ligand is shown with grey
carbon atoms. Also shown, with green carbon atoms, are residues that are hydrogen-bonded
to the ligand either directly, or through single buried water molecules. Residue labels are
underlined where the interactions involve side-chains and are therefore sequence specific. The
SAH forms several non-bonded interactions with the protein, for example, a clear π-stacking
interaction is observed between Phe178 and the adenine ring of SAH. However, for clarity,
residues that form only hydrophobic interactions with SAH are not shown.
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Stereoviews showing overlays of the NovP active site with those of other OMTs. In both panels
the protein backbones are shown in cartoon representation with NovP mainly in grey and the
second protein mainly in green. Key residues and ligands are shown in stick representation.
For NovP the atoms are in CPK colours, and for the second protein, all atoms are in green. The
labels in black refer to NovP; the green labels refer to the active site general base of the second
protein. Also shown is the disulphide bridge of NovP. (a) Comparison of NovP and SynOMT
(PDB code 3CBG). Note the clash between the NovP lid region (red) and the insertion loop of
SynOMT (blue). Also shown is the bound product (isoferulic acid) and the Mg2+ ion, which
are both coloured magenta. (b) Comparison of NovP and RebM (PDB code 3BUS).
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Proposed NovP mechanism. Comparisons with NovP structural homologues suggest that
Asp198 acts as the active site base which deprotonates the 4-OH of the noviose moiety (shown
with blue bonds). The putative 3-Asp cation binding site may serve to assist the deprotonation
as well as to correctly orient the substrate for methyltransfer from SAM (shown with green
bonds). All the Asp residues are strictly conserved in TylF superfamily members, whilst Trp58
is found in over 50% of the sequences. We would expect the Mg2+ to be octahedrally
coordinated, with the sixth coordination site most likely occupied by a water molecule; this
has been omitted for clarity.
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Substrate docking simulations. Surface representations of NovP with (a) lid present and (b) lid
removed. Colouring is as for Fig. 2. Displayed in stick form are the lowest energy poses from
each of the 'productive' 12 clusters from run 2 of the AutoDock4 simulations (i.e. mimicking
an activated enzyme-substrate complex). The lowest energy pose for the whole simulation is
shown with cyan carbons. (c) Stereoview showing the detail of the quaternary complex
involving the lowest energy pose. The Mg2+ ion is shown as an orange sphere. Also shown in
red is the position of Arg146 which may have a role in interacting with the substituent at C8
of the aminocoumarin ring. Note that the orientation of the noviose moiety is inverted relative
to that shown in Fig. 1 and Fig. 8.
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Table 2
Summary of X-ray data and model parameters for NovP
Data collection
     Space Group P2
      Cell parameters (Å/°) a = 51.81, b = 46.04, c = 61.22, β = 104.97
      Wavelength (Å) 1.488
      Resolution rangea (Å) 36.3-1.40 (1.42-1.40)
      Unique reflections 54638
      Completenessa (%) 98.8 (89.5)
      Redundancy 3.4
      Rmergea,b 0.057 (0.164)
    <I>/<σI>a 18.1 (4.2)
      Wilson B value (Å2) 17.6
Refinement
      Rcrystc (based on 95% of data; %) 14.5
      Rfreec (based on 5% of data; %) 16.2
      DPId (based on Rfree; Å) 0.048
      Ramachandran favoured/allowede (%) 96.6/100.0
      Ramachandran outlierse 0
      rmsd bond distances (Å) 0.013
      rmsd bond angles (º) 1.540
Contents of model (molecules/non-hydrogen atoms)
      Protein (residues/atoms) 242/1965
      S-adenosyl-L-homocysteine (molecules/atoms) 1/26
      Sulphate 2/10
      Ethylene glycol 2/8
      Waters 242
Average temperature factors (Å2)
      Main-chain atoms 14.6
      Side-chain atoms 18.1
      S-adenosyl-L-homocysteine 12.0
      Sulphate 28.4
      Ethylene glycol 25.2
      Waters 32.3
      Overall 18.1
a
The figures in brackets indicate the values for outer resolution shell.
b
Rmerge = Σh Σl |Ihl - <Ih>|/ Σh Σl <Ih>, where Il is the lth observation of reflection h and <Ih> is the weighted average intensity for all observations
l of reflection h.
c
The R-factors Rcryst and Rfree are calculated as follows: R = Σ(| Fobs - Fcalc |)/Σ| Fobs | × 100, where Fobs and Fcalc are the observed and
calculated structure factor amplitudes, respectively.
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d
Estimate of coordinate errors based on Rfree as calculated in REFMAC5.54
e
As calculated using MOLPROBITY.58
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